3316F Er- or pr- breast cancer
Other
Also known as: ER negative breast cancer, PR negative status, hormone receptor negative
Performance measure documenting estrogen receptor negative or progesterone receptor negative breast cancer. Quality metric for hormone receptor status determination.
Clinical Context
Quality measure documenting hormone receptor negative status indicating need for chemotherapy or other systemic therapy rather than endocrine therapy alone.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.